$ABCL a favorite long term but risk ahead if markets falter as revenue from Covid treatment stops coming in
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
